Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Rigshospitalet

🇩🇰Denmark

Country: 🇩🇰Denmark

Ownership: Private

Established: 1757-03-30

Employees: 10K

Market Cap: -

Website: http://www.rigshospitalet.dk

Clinical Trials

Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard Therapy

Phase 2

Completed

Conditions: Brain Neoplasms
Glioma

First Posted Date: 2007-04-20

Last Posted Date: 2011-06-29

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 54

Registration Number: NCT00463203

Locations: 🇩🇰
Aalborg University Hospital, Aalborg, Denmark
🇩🇰
Rigshospitalet, Copenhagen, Denmark
🇩🇰
Odense University Hospital, Odense, Denmark

Cetuximab, Bevacizumab and Irinotecan for Patients With Malignant Glioblastomas

Phase 2

Completed

Conditions: Malignant Gliomas

First Posted Date: 2007-04-20

Last Posted Date: 2008-12-11

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 32

Registration Number: NCT00463073

Locations: 🇩🇰
Aalborg University Hospital, Aalborg, Denmark
🇩🇰
Rigshospitalet, Copenhagen, Denmark
🇩🇰
Odense University Hospital, Odense, Denmark

Preoperative Prevention and Early Rehabilitation for Patients Undergoing Elective Spine Surgery

Not Applicable

Completed

Conditions: Spine Surgery

First Posted Date: 2007-04-13

Last Posted Date: 2007-04-13

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 60

Registration Number: NCT00459966

Locations: 🇩🇰
Head-Ortho-Centre, Anesthesiology Department, Rigshospitalet,, Copenhagen, Denmark

Cisplatin/Paclitaxel/Gemcitabine +/- Avastin in Patients With Unknown Primary Tumor

Phase 2

Withdrawn

Conditions: Unknown Primary Tumors

First Posted Date: 2007-04-10

Last Posted Date: 2015-05-08

Lead Sponsor: Rigshospitalet, Denmark

Registration Number: NCT00458315

Locations: 🇩🇰
Rigshospitalet, Dept of Oncology, Copenhagen, Denmark

New Indications for Ultrasound in the Staging of Cervical Cancer

Not Applicable

Withdrawn

Conditions: Cervical Cancer

First Posted Date: 2007-03-26

Last Posted Date: 2008-06-18

Lead Sponsor: Rigshospitalet, Denmark

Registration Number: NCT00451945

Locations: 🇩🇰
Copenhagen univercity hospital, Department of Radiology, section of ultrasound, Copenhagen, Denmark

Erlotinib as First-line Treatment of Advanced Non-small Cell Lung Cancer (NSCLC) for Patients Unfit for Chemotherapy

Phase 2

Terminated

Conditions: Non Small Cell Lung Cancer

Interventions: Drug: erlotinib

First Posted Date: 2007-03-26

Last Posted Date: 2014-12-11

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 24

Registration Number: NCT00452075

Locations: 🇩🇰
Department of Oncology, Rigshospitalet, Copenhagen, Denmark
🇩🇰
Department of Oncology, Odense University Hospital, Odense, Denmark
🇩🇰
Department of Oncology, Århus University Hospital, Århus, Denmark

Study of the Natural Variation in Strokevolume

Completed

Conditions: Stroke Volume Variation

First Posted Date: 2007-03-14

Last Posted Date: 2007-10-15

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 20

Registration Number: NCT00447200

Locations: 🇩🇰
Rigshospitalet, Copenhagen, Seeland, Denmark

Troponin-T for Detection of Perioperative Cardiovascular Events

Completed

Conditions: Myocardial Infarction
Cardiac Arrest

First Posted Date: 2007-03-07

Last Posted Date: 2008-05-30

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 100

Registration Number: NCT00443989

Locations: 🇩🇰
Herlev Hospital, Herlev, Copenhagen, Denmark
🇩🇰
Department of Anesthesiology and Intensive Care, Herlev University Hospital, Herlev, Copenhagen, Denmark

Malignant Wounds, Wound Treatment, Psycho-Social Support and Relaxation Therapy

Phase 3

Completed

Conditions: Cancer
Malignant Wounds

Interventions: Procedure: wound treatment
Other: psycho-social support
Other: relaxation therapy

First Posted Date: 2007-02-15

Last Posted Date: 2009-06-09

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 70

Registration Number: NCT00435474

Locations: 🇩🇰
Rigshospitalet, University hospital of Copenhagen. Oncology department, Copenhagen, Denmark

Neuroaxial Blokade and Blood Pressure

Not Applicable

Conditions: Hypovolemia

First Posted Date: 2007-02-15

Last Posted Date: 2010-03-25

Lead Sponsor: Rigshospitalet, Denmark

Target Recruit Count: 16

Registration Number: NCT00435422

Locations: 🇩🇰
Rigshospitalet, Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy